A double-blind, placebo controlled pharmacodynamic study of the effect of INCB013739 on systemic and adipose tissue 11betaHSD1 activity in obese, insulin resistant subjects.
Phase of Trial: Phase I/II
Latest Information Update: 23 May 2011
At a glance
- Drugs INCB 13739 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 25 Nov 2006 New trial record.